Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
In the last 90 days, Bicycle Therapeutics PLC insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Bicycle Therapeutics PLC changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 54 | 1 | 69 | +16 |
| Shares | 12.4M | 253 | 14.2M | +1.80M (+14.5%) |
| Value | $376.9M | $8.00K | $591.1M | +$214.2M (+56.8%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Bicycle Therapeutics PLC at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| First Light Asset Management, LLC | 732,731 | $30.5M | 2.01% |
| Ikarian Capital, LLC | 526,500 | $21.9M | 5.01% |
| Frazier Management LLC | 442,880 | $18.4M | 1.47% |
| Two Sigma Investments, LP | 92,192 | $3.83M | 0.01% |
| Altium Capital Management LP | 92,000 | $3.83M | 1.02% |
| Bellevue Group AG | 65,700 | $2.73M | 0.03% |
| Boothbay Fund Management, LLC | 54,906 | $2.28M | 0.09% |
| Two Sigma Advisers, LP | 46,700 | $1.94M | 0.01% |
| Acuta Capital Partners, LLC | 38,184 | $1.59M | 0.57% |
| Citadel Advisors LLC | 25,347 | $1.05M | 0.00% |
| Susquehanna International Group, LLP | 18,475 | $768.0K | 0.00% |
| Marshall Wace North America L.P. | 17,458 | $726.0K | 0.00% |
| Jump Financial, LLC | 17,200 | $715.0K | 0.05% |
| Goldman Sachs Group Inc | 14,863 | $618.0K | 0.00% |
| Cutler Group LP | 14,626 | $608.0K | 0.05% |
| Woodstock Corp | 10,682 | $444.0K | 0.05% |
| State Street Corp | 6,700 | $279.0K | 0.00% |
| Wells Fargo & Company | 6,104 | $254.0K | 0.00% |
| State of New Jersey Common Pension Fund D | 4,880 | $203.0K | 0.00% |
| HighMark Wealth Management LLC | 626 | $26.0K | 0.02% |
| Rockefeller Capital Management L.P. | 346 | $14.0K | 0.00% |
| Royal Bank of Canada | 104 | $4.00K | 0.00% |
Sold out (6)
Institutions that held Bicycle Therapeutics PLC at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| FIL Ltd | 525,623 | $16.0M |
| Millennium Management LLC | 20,363 | $618.0K |
| Renaissance Technologies LLC | 14,600 | $443.0K |
| WealthShield Partners, LLC | 879 | $27.0K |
| Lindbrook Capital, LLC | 500 | $15.0K |
| Advisory Services Network, LLC | 100 | $3.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Bicycle Therapeutics PLC at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Castleview Partners, LLC | 253 | $8.00K |